Impact of preventive therapy on the risk of breast cancer among women with benign breast disease
dc.contributor.author | Cuzick, J | en_US |
dc.contributor.author | Sestak, I | en_US |
dc.contributor.author | Thorat, MA | en_US |
dc.date.accessioned | 2015-09-02T08:18:27Z | |
dc.date.accessioned | 2016-05-05T10:50:49Z | |
dc.date.issued | 2015-11 | en_US |
dc.date.submitted | 2016-03-22T16:08:05.571Z | |
dc.identifier.issn | 0960-9776 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/8411 | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/12172 | |
dc.description | Licensed Creative Commons Attribution Non-Commercial No Derivatives License | en_US |
dc.format.extent | S51 - S55 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BREAST | en_US |
dc.relation.replaces | http://qmro.qmul.ac.uk/xmlui/handle/123456789/8411 | |
dc.relation.replaces | 123456789/8411 | |
dc.rights | CC-BY | |
dc.subject | Benign breast disease | en_US |
dc.subject | Breast cancer prevention | en_US |
dc.subject | Atypical hyperplasia | en_US |
dc.subject | Breast cancer risk | en_US |
dc.subject | Tamoxifen | en_US |
dc.subject | Aromatase inhibitors | en_US |
dc.title | Impact of preventive therapy on the risk of breast cancer among women with benign breast disease | en_US |
dc.type | Article | |
dc.rights.holder | © 2015 The Authors | |
dc.identifier.doi | 10.1016/j.breast.2015.07.013 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000365041000013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 24 | en_US |
qmul.funder | Cancer Prevention::Cancer Research UK | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Cancer Prevention [1199]